ArticleMolecular biology reports2025
Role of Interleukin 37 and its polymorphism (rs3811047) in children with type I diabetes.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 1 diabetes (T1D) is a multifaceted autoimmune condition. Interleukin-37 (IL-37), a cytokine from the IL-1 family, is recognized for its anti-inflammatory effects and its involvement in the progression of various autoimmune diseases (ADs). Despite this, the exact relationships are not fully clear. The objective of this study was to assess serum IL-37 levels and the polymorphism (rs3811047) to investigate its possible role in T1D.
methodsThe study involved 46 individuals with Type 1 Diabetes (T1D) and 45 healthy controls. Serum IL-37 levels were quantified using enzyme-linked immunosorbent assay (ELISA). Genomic DNA was extracted with a specialized DNA extraction kit. The specific single nucleotide polymorphism (SNP) in the IL-37 gene (rs3811047) was then genotyped using real-time polymerase chain reaction (RT-PCR).
resultsThe serum concentrations of IL-37 did not show a significant difference between individuals with T1D and the control group, with a P-value of 0.7. However, our results revealed a significant correlation between T1D and the IL-37 polymorphism (rs3811047). Both the AG and GG genotypes were strongly associated with an elevated risk of developing T1D in comparison to the control group. Furthermore, the frequency of the G allele in rs3811047 was notably higher in the T1D group (56.5%) compared to the control group (32.2%).
conclusionsThese findings suggest that the rs3811047 variant in the IL-37 gene is a significant genetic marker linked to an increased susceptibility to T1D. The AG and GG genotypes, along with the G allele, are associated with a higher risk.
Indexed as
Identifiers
40622574What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.